Literature DB >> 839106

Rheological evaluation of hemoglobin S and hemoglobin C hemoglobinopathies.

F Self, L V McIntire, B Zanger.   

Abstract

The concept of optimum hematocrit was used to compare the rheology of bloods from patients with various hemoglobin S and hemoglobin C hemoglobinopathies. The technique involved the utilization of cone and plate viscometric data to predict average flow rates under representative physiological-fluid mechanical conditions. The shape of the curve relating optimum hematocrit to oxygen tension, rather than the absolute magnitude of the optimum hematocrit at fixed oxygen tension, is shown to give an indication of clinical severity of the disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 839106

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  6 in total

Review 1.  Sickle cell vasoocclusion: many issues and some answers.

Authors:  D K Kaul; R L Nagel
Journal:  Experientia       Date:  1993-01-15

2.  Blood rheology and proliferative retinopathy in sickle cell-haemoglobin C disease.

Authors:  B E Serjeant; K P Mason; P I Condon; R J Hayes; M W Kenny; J Stuart; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1984-05       Impact factor: 4.638

3.  Rheological effects of bed rest in sickle cell disease.

Authors:  A J Keidan; J Stuart
Journal:  J Clin Pathol       Date:  1987-10       Impact factor: 3.411

4.  Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion.

Authors:  H C Chen; J Wiek; A Gupta; A Luckie; E M Kohner
Journal:  Br J Ophthalmol       Date:  1998-02       Impact factor: 4.638

5.  Painful sickle cell crises precipitated by stopping prophylactic exchange transfusions.

Authors:  A J Keidan; S S Marwah; G R Vaughan; I M Franklin; J Stuart
Journal:  J Clin Pathol       Date:  1987-05       Impact factor: 3.411

6.  Some aspects of the pathophysiology of homozygous Hb CC erythrocytes.

Authors:  M E Fabry; D K Kaul; C Raventos; S Baez; R Rieder; R L Nagel
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.